Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,752 | 22,755 | 43,108 | 9,915 | 10,441 |
| Marketable Securities | N/A | N/A | N/A | 5,390 | 6,368 |
| Receivables | 3,470 | 1,392 | 3,880 | 1,018 | 925 |
| Inventories | 53,065 | 18,616 | 12,628 | 5,020 | 3,446 |
| Other current assets | 0 | 0 | 1,500 | 0 | 0 |
| TOTAL | $85,820 | $44,530 | $62,342 | $21,657 | $21,290 |
| Non-Current Assets | |||||
| PPE Net | 31,741 | 30,116 | 30,467 | 2,001 | 2,397 |
| Intangibles | 6,689 | 7,534 | 8,379 | 0 | 0 |
| Other Non-Current Assets | 2,840 | 6,697 | 6,832 | 27 | 27 |
| TOTAL | $41,270 | $44,347 | $45,677 | $2,028 | $2,424 |
| Total Assets | $127,091 | $88,877 | $108,019 | $23,685 | $23,715 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 229 | N/A | N/A | N/A | 15 |
| Accounts payable and accrued liabilities | 9,175 | 5,900 | 5,921 | 2,565 | 2,088 |
| Accrued Expenses | 4,481 | 3,552 | 3,377 | 2,385 | 1,968 |
| Other current liabilities | N/A | N/A | N/A | 17 | N/A |
| TOTAL | $14,028 | $9,625 | $9,440 | $11,223 | $4,217 |
| Non-Current Liabilities | |||||
| Long Term Debt | 83,199 | 41,315 | 40,211 | 12,322 | 14,284 |
| Deferred Revenues | 143 | 143 | 143 | 145 | 145 |
| Other Non-Current Liabilities | 107 | 15,643 | 15,488 | 1,908 | 1,561 |
| TOTAL | $86,870 | $59,481 | $58,246 | $16,920 | $18,677 |
| Total Liabilities | $100,898 | $69,106 | $67,686 | $28,142 | $22,894 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,345 | 46,353 | 45,317 | 12,887 | 10,713 |
| Common Shares | 6 | 5 | 5 | 1 | 1 |
| Retained earnings | -264,717 | -216,437 | -150,694 | -106,935 | -87,420 |
| TOTAL | $26,193 | $19,770 | $40,333 | $-4,457 | $821 |
| Total Liabilities And Equity | $127,091 | $88,877 | $108,019 | $23,685 | $23,715 |